Ledger.Open graph →
SEC Form D · Amendment · filed June 3, 2024

Infinity Bio, Inc

Offering
$4.5M
Sold
$4.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Matthew Hellauer · Baltimore, MDDirectorHerman M. Scholtz · Baltimore, MDDirectorCaroline Popper · Baltimore, MDDirectorJoy M. Nassif · Baltimore, MDExec · DirectorBenjamin Larman · Baltimore, MDExec · DirectorBenjamin Larman · Baltimore, MDExec · DirectorMatthew Hellauer · Baltimore, MDDirectorHerman M. Scholtz · Baltimore, MDDirectorJoy M. Nassif · Baltimore, MDExec · DirectorCaroline Popper · Baltimore, MDDirectorSteven W. Heanly · London, United KingdomDirectorAndrew J. Aitken · London, United KingdomExec · DirectorRodolphe T. Vallee · Miami, FLDirectorAmerigo Contini · Austin, TXExec · DirectorDaniel Niles · Plantation, FLDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗